8FVJ image
Deposition Date 2023-01-19
Release Date 2023-09-06
Last Version Date 2025-05-14
Entry Detail
PDB ID:
8FVJ
Keywords:
Title:
Dimeric form of HIV-1 Vif in complex with human CBF-beta, ELOB, ELOC, and CUL5
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.54 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Core-binding factor subunit beta
Gene (Uniprot):CBFB
Chain IDs:A (auth: 0), F (auth: 5)
Chain Length:157
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Virion infectivity factor
Gene (Uniprot):vif
Chain IDs:B (auth: 1), G (auth: 6)
Chain Length:178
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:Cullin-5
Gene (Uniprot):CUL5
Chain IDs:E (auth: 2), J (auth: 7)
Chain Length:314
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Elongin-B
Gene (Uniprot):ELOB
Chain IDs:C (auth: 3), H (auth: 8)
Chain Length:102
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Elongin-C
Gene (Uniprot):ELOC
Chain IDs:D (auth: 4), I (auth: 9)
Chain Length:96
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H.
Nat Commun 14 5241 5241 (2023)
PMID: 37640699 DOI: 10.1038/s41467-023-40955-x

Abstact

Human APOBEC3 (A3) cytidine deaminases are antiviral factors that are particularly potent against retroviruses. As a countermeasure, HIV-1 uses a viral infectivity factor (Vif) to target specific human A3s for proteasomal degradation. Vif recruits cellular transcription cofactor CBF-β and Cullin-5 (CUL5) RING E3 ubiquitin ligase to bind different A3s distinctively, but how this is accomplished remains unclear in the absence of the atomic structure of the complex. Here, we present the cryo-EM structures of HIV-1 Vif in complex with human A3H, CBF-β and components of CUL5 ubiquitin ligase (CUL5, ELOB, and ELOC). Vif nucleates the entire complex by directly binding four human proteins, A3H, CBF-β, CUL5, and ELOC. The structures reveal a large interface area between A3H and Vif, primarily mediated by an α-helical side of A3H and a five-stranded β-sheet of Vif. This A3H-Vif interface unveils the basis for sensitivity-modulating polymorphism of both proteins, including a previously reported gain-of-function mutation in Vif isolated from HIV/AIDS patients. Our structural and functional results provide insights into the remarkable interplay between HIV and humans and would inform development efforts for anti-HIV therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures